• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喷雾干燥有机溶剂混悬液中的乳糖,用于肺部气溶胶给药。

Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.

机构信息

Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, Pharmacy and Bank Building A15, The University of Sydney, NSW 2006, Australia.

Hangzhou Chance Pharmaceuticals, Hangzhou, China.

出版信息

Int J Pharm. 2020 Dec 15;591:119984. doi: 10.1016/j.ijpharm.2020.119984. Epub 2020 Oct 16.

DOI:10.1016/j.ijpharm.2020.119984
PMID:33069893
Abstract

Lactose is widely used as an approved excipient for dry powder inhaler (DPI) products. Spray drying technique is a rapid method for converting a liquid feed into inhalable dried particles. However, spray-dried (SD) lactose powders produced from solutions are mostly amorphous and particularly unstable when exposed to moisture. In the present study, we explored the use of spray drying suspensions containing crystalline lactose particles in an organic solvent, and investigated the physicochemical properties of the resulting powders. The solution formulation was spray dried as a control. Two conditioned crystalline lactose samples were used for suspension formulations: Lactohale (LH) 300 lactose and jet-milled (JM) lactose micronized from LH300. The suspension formulations each contained 12 mg/ml suspended crystalline lactose particles (either LH300 or JM lactose) in isopropyl alcohol. The solution formulation contained 60 mg/ml lactose in water. The SD powders were stored under 25 °C/60% RH and 40 °C/75% RH for 3 months. The particulate properties and in vitro dispersion performance were examined at various time points. The SD lactose obtained from solution recrystallized and was no longer dispersible after 1-day storage at both storage conditions. The suspension SD JM lactose powder showed deterioration in the particulate properties and dispersibility over time, but more gradually. In contrast, the SD LH300 powder was stable, with its particulate properties and dispersion performance (FPF: ~12%) remaining the same after 3-months storage at 25 °C/60% RH. The SD LH300 stored at 40 °C/75% RH showed no change in particulate properties, but the FPF decreased over 3 months. Overall, SD lactose powders obtained from suspension demonstrated superior stability performance compared to SD lactose obtained from solution.

摘要

乳糖被广泛用作干粉吸入剂(DPI)产品的批准赋形剂。喷雾干燥技术是一种将液体饲料转化为可吸入干燥颗粒的快速方法。然而,从溶液中喷雾干燥(SD)的乳糖粉末大多是无定形的,当暴露于水分时特别不稳定。在本研究中,我们探索了使用含有结晶乳糖颗粒的喷雾干燥悬浮液的方法,并研究了所得粉末的物理化学性质。该溶液制剂作为对照进行喷雾干燥。两种条件结晶乳糖样品用于悬浮液配方:Lactohale(LH)300 乳糖和从 LH300 微粉化的喷射磨(JM)乳糖。悬浮液配方各含有 12mg/ml 悬浮结晶乳糖颗粒(LH300 或 JM 乳糖)在异丙醇中。溶液配方含有 60mg/ml 乳糖在水中。SD 粉末在 25°C/60%RH 和 40°C/75%RH 下储存 3 个月。在不同时间点检查 SD 粉末的颗粒特性和体外分散性能。从溶液中获得的 SD 乳糖重新结晶,在两种储存条件下储存 1 天后不再可分散。随着时间的推移,悬浮 SD JM 乳糖粉末的颗粒特性和分散性逐渐恶化,但更缓慢。相比之下,SD LH300 粉末是稳定的,其颗粒特性和分散性能(FPF:~12%)在 25°C/60%RH 下储存 3 个月后保持不变。在 40°C/75%RH 下储存的 SD LH300 粉末的颗粒特性没有变化,但 FPF 在 3 个月内下降。总体而言,与从溶液中获得的 SD 乳糖粉末相比,从悬浮液中获得的 SD 乳糖粉末表现出更好的稳定性。

相似文献

1
Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.喷雾干燥有机溶剂混悬液中的乳糖,用于肺部气溶胶给药。
Int J Pharm. 2020 Dec 15;591:119984. doi: 10.1016/j.ijpharm.2020.119984. Epub 2020 Oct 16.
2
Co-spray dried hydrophobic drug formulations with crystalline lactose for inhalation aerosol delivery.喷雾干燥共处理疏水性药物制剂与结晶乳糖用于吸入气雾剂递送。
Int J Pharm. 2021 Jun 1;602:120608. doi: 10.1016/j.ijpharm.2021.120608. Epub 2021 Apr 20.
3
Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.保护疏水性氨基酸,防止高吸湿性喷雾干燥粉末的雾化性能因水分引起的劣化。
Eur J Pharm Biopharm. 2017 Oct;119:224-234. doi: 10.1016/j.ejpb.2017.06.023. Epub 2017 Jun 24.
4
Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.协同黏菌素增强吸入型无定形环丙沙星粉末制剂的物理稳定性和雾化效果
Mol Pharm. 2018 Sep 4;15(9):4004-4020. doi: 10.1021/acs.molpharmaceut.8b00445. Epub 2018 Aug 3.
5
Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.用于靶向肺部递送的先进喷雾干燥微粒/纳米微粒甘露醇粉末作为干粉吸入器的设计、表征和气溶胶分散性能建模。
J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):81-93. doi: 10.1089/jamp.2013.1078. Epub 2014 Feb 6.
6
L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.L-亮氨酸作为一种辅料对高吸湿性喷雾干燥粉末体外雾化性能的防潮作用。
Eur J Pharm Biopharm. 2016 May;102:132-41. doi: 10.1016/j.ejpb.2016.02.010. Epub 2016 Mar 9.
7
Raman spectroscopic evaluation of crystallinity, chemical composition and stability of pharmaceutical powder aerosols.拉曼光谱法评估药物粉末气溶胶的结晶度、化学成分和稳定性。
Int J Pharm. 2022 Jan 5;611:121341. doi: 10.1016/j.ijpharm.2021.121341. Epub 2021 Dec 2.
8
Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.万古霉素和克拉霉素多功能控释粒子的先进喷雾干燥设计、理化特性表征和干粉吸入气溶胶的气溶胶分散性能,用于靶向呼吸递药。
Int J Pharm. 2013 Oct 15;455(1-2):374-92. doi: 10.1016/j.ijpharm.2013.06.047. Epub 2013 Jun 29.
9
Preparation and Characterization of Inhalable Ivermectin Powders as a Potential COVID-19 Therapy.吸入用伊维菌素粉末的制备与特性研究——一种有潜力的 COVID-19 疗法。
J Aerosol Med Pulm Drug Deliv. 2022 Oct;35(5):239-251. doi: 10.1089/jamp.2021.0059. Epub 2022 Mar 11.
10
Storage stability of phage-ciprofloxacin combination powders against Pseudomonas aeruginosa respiratory infections.噬菌体-环丙沙星联合粉剂对抗铜绿假单胞菌呼吸道感染的储存稳定性。
Int J Pharm. 2020 Dec 15;591:119952. doi: 10.1016/j.ijpharm.2020.119952. Epub 2020 Oct 12.

引用本文的文献

1
Long-term Storage Stability of Inhalable Phage Powder Formulations: A Four-Year Study.可吸入噬菌体粉末制剂的长期储存稳定性:一项为期四年的研究。
AAPS J. 2025 Aug 4;27(5):128. doi: 10.1208/s12248-025-01112-y.
2
Human Milk Oligosaccharides: Potential Applications in COVID-19.人乳寡糖:在新型冠状病毒肺炎中的潜在应用
Biomedicines. 2022 Feb 1;10(2):346. doi: 10.3390/biomedicines10020346.
3
Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter?用α-乳糖调节Gal-9/TIM-3免疫检查点。乳糖的异头物重要吗?
Cancers (Basel). 2021 Dec 18;13(24):6365. doi: 10.3390/cancers13246365.